ORA - Oxford University Research Archive

« Previous | 1 - 10 of 47 | Next »

1

Journal article

High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome

Chilton, L, Buck, G, Harrison, CJ, et al.
2014-07-05

2

Conference

Outcome of 1,229 Adult Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia (B-ALL) Patients (pts) From the International UKALLXII/E2993 Trial: No Difference In Results Between B Cell Immunophenotypic Subgroups

Lrrzow, MR, Buck, G, Dewald, G, et al.
2010-11-19

3

Conference

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia (ALL): Analysis of cytogenetic data from 1,235 patients on the medical research council (MRC) UKALLXII/Eastern cooperative oncology group (ECOG) 2993 trial.

Moorman, AV, Harrison, CJ, Richards, SM, et al.
2005-11-16

4

Journal article

Response: chemotherapy versus allogeneic transplantation in adult patients with acute lymphoblastic leukemia in first remission--not a time for dogma.

Gupta, V, Richards, S, Rowe, JM
2013-06-05

5

Conference

Outcome of 1,229 Adult Philadelphia Chromosome Negative B Acute Lyrnphoblastic Leukemia (B ALL) Patients (pts) From the International UKALLXII/E2993 Trial No Difference In Results Between B Cell Immuno phenotypic Subgroups

Lrrzow, MR, Buck, G, Dewald, G, et al.
2010-11-19

6

Conference

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia

Moorman, AV, Harrison, CJ, Buck, GAN, et al.
2007-04-05

7

Journal article

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study.

Fielding, AK, Richards, SM, Chopra, R, et al.
2007-02-05

8

Journal article

Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial.

Sive, JI, Buck, G, Fielding, A, et al.
2012-05-05

9

Conference

Imatinib Significantly Enhances Long-Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia; Final Results of the UKALLXII/ECOG2993 Trial

Fielding, AK, Buck, G, Lazarus, HM, et al.
2010-11-19

10

Conference

Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial

Sive, JI, Buck, G, Fielding, A, et al.
2010-11-19

TO TOP